Position history for RA CAPITAL MANAGEMENT, L.P.'s holdings in TAYSHA GENE THERAPIES INC
RA CAPITAL MANAGEMENT, L.P. holds 23.6M shares of TSHA (TAYSHA GENE THERAPIES INC), worth $129.6M as of 2025-Q4. TSHA represents 1.3% of RA CAPITAL MANAGEMENT, L.P.'s portfolio.
Current Value
$129.6M
Current Shares
23.6M
Total Value Change
+$105.2M
Total Shares Change
+12.7M
Other major holders of TSHA: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, Avoro Capital Advisors LLC, BlackRock, Inc., MORGAN STANLEY, RTW INVESTMENTS, LP
Unchanged |
| 23.6M |
0.0% |
| $129.6M |
| 1.3% |
| $5.66 |
0 |
| 2025-Q3 | Unchanged | 23.6M | 0.0% | $77M | 0.9% | $3.16 | 0 |
| 2025-Q2 | Increased | 23.6M | +116.7% | $54.4M | 0.9% | $2.38 | 67 |
| 2025-Q1 | Unchanged | 10.9M | 0.0% | $15.1M | 0.3% | $1.93 | 0 |
| 2024-Q4 | Unchanged | 10.9M | 0.0% | $18.8M | 0.3% | $1.73 | 0 |
| 2024-Q3 | Unchanged | 10.9M | 0.0% | $21.9M | 0.3% | $2.07 | 0 |
| 2024-Q2 | Unchanged | 10.9M | 0.0% | $24.4M | 0.3% | $2.24 | 0 |